- Home
- UHAL vs EXAS Comparison
UHAL vs EXAS Comparison
Compare UHAL & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UHAL
- EXAS
- Stock Information
- Founded
- UHAL 1945
- EXAS 1995
- Country
- UHAL United States
- EXAS United States
- Employees
- UHAL N/A
- EXAS N/A
- Industry
- UHAL Rental/Leasing Companies
- EXAS Medical Specialities
- Sector
- UHAL Consumer Discretionary
- EXAS Health Care
- Exchange
- UHAL Nasdaq
- EXAS Nasdaq
- Market Cap
- UHAL 11.2B
- EXAS 11.0B
- IPO Year
- UHAL N/A
- EXAS N/A
- Fundamental
- Price
- UHAL $52.68
- EXAS $68.80
- Analyst Decision
- UHAL
- EXAS Strong Buy
- Analyst Count
- UHAL 0
- EXAS 18
- Target Price
- UHAL N/A
- EXAS $72.44
- AVG Volume (30 Days)
- UHAL 126.1K
- EXAS 2.9M
- Earning Date
- UHAL 11-05-2025
- EXAS 11-03-2025
- Dividend Yield
- UHAL N/A
- EXAS N/A
- EPS Growth
- UHAL N/A
- EXAS N/A
- EPS
- UHAL 1.19
- EXAS N/A
- Revenue
- UHAL $5,972,459,000.00
- EXAS $3,082,033,000.00
- Revenue This Year
- UHAL $3.18
- EXAS $16.68
- Revenue Next Year
- UHAL $3.71
- EXAS $12.36
- P/E Ratio
- UHAL $44.27
- EXAS N/A
- Revenue Growth
- UHAL 5.86
- EXAS 14.47
- 52 Week Low
- UHAL $51.99
- EXAS $38.81
- 52 Week High
- UHAL $75.19
- EXAS $72.81
- Technical
- Relative Strength Index (RSI)
- UHAL 36.45
- EXAS 69.46
- Support Level
- UHAL $51.99
- EXAS $66.14
- Resistance Level
- UHAL $55.12
- EXAS $72.81
- Average True Range (ATR)
- UHAL 1.17
- EXAS 2.18
- MACD
- UHAL -0.06
- EXAS -0.10
- Stochastic Oscillator
- UHAL 19.78
- EXAS 59.98
About UHAL U-Haul Holding Company
U-Haul Holding Co is an American moving truck, trailer, and self-storage rental company. The company also provides moving boxes, packing supplies, LPG (propane) refills, trailer hitch and wiring installation, storage container rentals, and other services. It has three reportable segments Moving and Storage, Property and Casualty Insurance, and Life Insurance. The majority of its revenue comes from the Moving and Storage segment.
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.